Analysis of High-Dose Ascorbate-Induced Cytotoxicity in Human Glioblastoma Cells and the Role of Dehydroascorbic Acid and Iron.
ascorbate
cancer
glioblastoma
iron
reactive oxygen species
vitamin C
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
10 Sep 2024
10 Sep 2024
Historique:
received:
25
07
2024
revised:
02
09
2024
accepted:
05
09
2024
medline:
28
9
2024
pubmed:
28
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
Several studies have demonstrated, both in vitro and in animal models, the anti-tumor efficacy of high-dose ascorbate treatment against a variety of tumor entities, including glioblastoma, the most common and aggressive primary malignant brain tumor. The aim of this study was to investigate the effects of high-dose ascorbate as well as dehydroascorbic acid on human glioblastoma cell lines and to evaluate different treatment conditions for the combined administration of ascorbate with magnesium (Mg
Identifiants
pubmed: 39334754
pii: antiox13091095
doi: 10.3390/antiox13091095
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Dr. Hans Fritz-Stiftung
ID : 3140080501
Organisme : Pascoe pharmazeutische Praeparate GmbH
ID : D.31.15100 and D.32.22506
Organisme : Ministry of Rural Affairs and Consumer Protection Baden-Württemberg
ID : AZ 16 (34) 8402.43 / 0454 E
Organisme : Else-Uebelmesser-Stiftung
ID : D3021947; reference: GzV 1.14